Showing results (71-80 of 101) with videos related to
Sort By:
Pageof 11
Journal of Thrombosis and Haemostasis : JTH|December 21, 2020
Management of elective procedures in low von Willebrand factor patients in the LoVIC studyDearbhla Doherty, Michelle Lavin, Jamie M O'Sullivan, et al.Blood Advances|May 6, 2022
Enhanced VWF clearance in low VWF pathogenesis: limitations of the VWFpp/VWF:Ag ratio and clinical significanceDearbhla Doherty, Michelle Lavin, Mary Byrne, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 2013
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistancePhillip A Schwartz, Petr Kuzmic, James Solowiej, et al.European Journal of Haematology|March 8, 2022
Pain and functional disability amongst adults with moderate and severe haemophilia from the Irish personalised approach to the treatment of haemophilia (iPATH) studyMegan Kennedy, Brian O' Mahony, Sheila Roche, et al.Atmospheric Measurement Techniques|May 9, 2022
Stationary and portable multipollutant monitors for high-spatiotemporal-resolution air quality studies including online calibrationColby Buehler, Fulizi Xiong, Misti Levy Zamora, et al.British Journal of Haematology|June 23, 2021
Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentationsMichelle Lavin, Patrick T Elder, Denis O'Keeffe, et al.Structure (London, England : 1993)|December 17, 2009
Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active siteDaniel M Himmel, Karen A Maegley, Tom A Pauly, et al.Cancer Biology & Therapy|September 13, 2008
Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activationMargaret A Park, Guo Zhang, Aditi Pandya Martin, et al.British Journal of Haematology|April 25, 2020
COVID19 coagulopathy in Caucasian patientsHelen Fogarty, Liam Townsend, Cliona Ni Cheallaigh, et al.The Journal of Biological Chemistry|December 28, 2020
Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1Kevin Ryan, Ben Bolaňos, Marissa Smith, et al.Pageof 11